ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: One of the earliest attempts to model human CML in immunodeficient mouse models dates back to the late '70s, where the BCR-ABL+ cell line K562 was injected into nude mice which grew as solid vascularized tumors containing cells like those seen in the patient and in the cultures [43].